Cargando…

Relapse of Non-Hodgkin's Lymphoma Involving the Trachea: Acute Subglottic Obstruction

Relapsing lymphoma involving the trachea causing tracheal obstruction is exceedingly uncommon. Despite its rarity, it should be considered in the differential diagnosis when a patient with known lymphoma presents with signs of airway obstruction such as stridor. We report an unusual case of relapsin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Allen Y., Wang, Jeffrey T., Shen, Yi, Levin, Brett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965939/ https://www.ncbi.nlm.nih.gov/pubmed/24711946 http://dx.doi.org/10.1155/2014/230682

Ejemplares similares

Subglottic stenosis and acute airway obstruction
por: Hariharan, Uma
Publicado: (2014)

Complicated airway management in a neonate of congenital trachea-oesophageal fistula with subglottic stenosis
por: Kerai, Sukhyanti, et al.
Publicado: (2016)

Non-Hodgkin lymphoma with relapses in the lacrimal glands
por: Couceiro, Rita, et al.
Publicado: (2015)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

A Rare Case of Angioleiomyoma Arising in the Subglottic Area to Upper Trachea of a Patient with Underlying Asthma
por: Sung, Yeoun Eun, et al.
Publicado: (2017)

Obstructions in the Larynx and Trachea
por: Ingals, E. Fletcher
Publicado: (1882)

Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
por: Weide, Rudolf
Publicado: (2008)

ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)

Generalized granuloma annulare heralding relapse of non-Hodgkin lymphoma
por: King, Sarah A., et al.
Publicado: (2020)

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
por: Phillips, Tycel, et al.
Publicado: (2022)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
por: Beard, S M, et al.
Publicado: (2000)

Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma
por: Garrett, May, et al.
Publicado: (2019)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015)

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

Non-Hodgkin lymphoma with primary involvement of skeletal muscle
por: Alamdari, Azam, et al.
Publicado: (2014)

Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
por: Kim, Ki-Hyang, et al.
Publicado: (2009)

Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma
por: Bröske, Ann-Marie E., et al.
Publicado: (2022)

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
por: Gaudio, Francesco, et al.
Publicado: (2011)

Paraspinal mass as a presentation in relapsed Hodgkin lymphoma
por: Dua, Vikas, et al.
Publicado: (2013)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
por: Voorhees, Timothy J, et al.
Publicado: (2020)

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma
por: Tarekegn, Kidist, et al.
Publicado: (2021)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
por: Kasamon, Yvette L., et al.
Publicado: (2017)

Relapse of Hodgkin's disease revealed by skin involvement
por: Abakarim, Ouadii, et al.
Publicado: (2022)

Surgery of the Trachea
por: Allen, Mark S.
Publicado: (2015)

Renal Involvement in Non-Hodgkin Lymphoma: Proven by Renal Biopsy
por: Li, Shi-Jun, et al.
Publicado: (2014)

Primary non-Hodgkin’s Lymphoma of the Bladder with Bone Marrow Involvement
por: Oh, Kil Chan, et al.
Publicado: (2003)

Pachymeningeal Involvement with Blindness as the Presenting Manifestation of Non-Hodgkin Lymphoma
por: Singh, Charanpreet, et al.
Publicado: (2018)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
por: Chao, Mark P
Publicado: (2013)

BRAF mutations in non-Hodgkin's lymphoma
por: Lee, J W, et al.
Publicado: (2003)

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
por: Siddiqi, Tanya, et al.
Publicado: (2014)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
por: Fedele, Roberta, et al.
Publicado: (2015)

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
por: Salihoglu, A., et al.
Publicado: (2014)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
por: Hallam, Simon
Publicado: (2018)

PB2064: RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH RADIOTHERAPY
por: Kallel, F., et al.
Publicado: (2022)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c59qatac45illqob0haqf8f1b3